Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Principles of interferon induction therapy.

T J Layden1

  • 1Department of Medicine, University of Illinois at Chicago Medical Center, 60612, USA.

The American Journal of Medicine
|February 1, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An assessment of racial differences in the upper limits of normal ALT levels in children and the effect of obesity on elevated values.

Pediatric obesity·2016
Same author

Characterizing hepatitis B stigma in Chinese immigrants.

Journal of viral hepatitis·2012
Same author

Hepatocyte proliferation and hepatitis C virus kinetics during treatment.

Clinical pharmacology and therapeutics·2011
Same author

Very early prediction of response to HCV treatment with PEG-IFN-alfa-2a and ribavirin in HIV/HCV-coinfected patients.

Journal of viral hepatitis·2010
Same author

The prevalence and clinical correlates of elevated ALT levels in an urban Chinatown community.

Journal of viral hepatitis·2009
Same author

A novel anticancer agent ARC antagonizes HIV-1 and HCV.

Oncogene·2006
Same journal

Mineralocorticoid Antagonists for Post-MI HFpEF: Plausible Biology Meets Low Residual Risk?

The American journal of medicine·2026
Same journal

GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

The American journal of medicine·2026
Same journal

Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

The American journal of medicine·2026
Same journal

Cave Canem - Beware of the Dog.

The American journal of medicine·2026
Same journal

Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

The American journal of medicine·2026
Same journal

Mesenteric panniculitis.

The American journal of medicine·2026
See all related articles

Induction therapy with higher interferon doses improves hepatitis C virus (HCV) response. A rapid viral decrease after dosing predicts sustained virologic response.

Area of Science:

  • Hepatology
  • Virology
  • Pharmacology

Background:

  • Hepatitis C virus (HCV) infection requires effective treatment strategies.
  • Interferon-alpha therapy is a primary treatment for HCV.
  • Optimizing interferon-alpha dosing enhances sustained virologic response rates.

Purpose of the Study:

  • To evaluate induction therapy strategies for improving HCV treatment outcomes.
  • To analyze the viral kinetics following interferon-alpha administration in HCV patients.

Main Methods:

  • Utilized induction therapy with higher, daily interferon-alpha doses.
  • Monitored HCV viral load and kinetics post-interferon administration.
  • Correlated viral kinetics with treatment response and patient factors.

Related Experiment Videos

Main Results:

  • Interferon-alpha exhibits a biphasic dose-dependent viral reduction.
  • Rapid initial viral decline reflects inhibited viral production.
  • Slower second-phase decline, reflecting hepatocyte death, predicts treatment success.
  • HCV genotypes 2 and 3 respond better to interferon than genotype 1.

Conclusions:

  • Induction therapy may improve sustained virologic response in HCV patients.
  • Early, brisk viral decline during interferon therapy is a key predictor of treatment efficacy.
  • HCV genotype influences treatment response to interferon-alpha.